Covid-19 case with prolonged neutropenia

In this article, we present the follow-up and treatment process of neutropenia, which develops during COVID-19 infection in a healthy adult and lasts for approximately 45 days. When the patient applied with the complaints of weakness and joint pain, the PCR test was positive and neutropenia and lymp...

Full description

Saved in:
Bibliographic Details
Published in:Pamukkale Medical Journal 2022-01, Vol.15 (2), p.391-394
Main Authors: Yiğit,Nilüfer, Ünver Koluman,Başak, Uğurlu,Erhan, Altınışık Ergur,Göksel
Format: Article
Language:English
Subjects:
Coronaviruses
COVID-19
Infections
Neutropenia
Sağlık Hizmetleri
Tıp
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this article, we present the follow-up and treatment process of neutropenia, which develops during COVID-19 infection in a healthy adult and lasts for approximately 45 days. When the patient applied with the complaints of weakness and joint pain, the PCR test was positive and neutropenia and lymphopenia were detected in the laboratory examination. Granulocyte-Colony Stimulating Factor (G-CSF) treatment was started in order to prevent the development of secondary infection to the patient, who was evaluated for additional medical treatment for neutropenia while the COVID-19 treatment was continuing. However, it was observed that neutropenia returned to normal after 1.5 months. Neutropenia secondary to COVID-19 infection can be seen in healthy adults and it is thought that the use of G-CSF in the treatment will be beneficial.
ISSN:1309-9833
1308-0865
DOI:10.31362/patd.1017368